181 related articles for article (PubMed ID: 29190264)
1. Fractional-Dose Inactivated Poliovirus Vaccine Campaign - Sindh Province, Pakistan, 2016.
Pervaiz A; Mbaeyi C; Baig MA; Burman A; Ahmed JA; Akter S; Jatoi FA; Mahamud A; Asghar RJ; Azam N; Shah MN; Laghari MA; Soomro K; Wadood MZ; Ehrhardt D; Safdar RM; Farag N
MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1295-1299. PubMed ID: 29190264
[TBL] [Abstract][Full Text] [Related]
2. Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign - Telangana State, India, June 2016.
Bahl S; Verma H; Bhatnagar P; Haldar P; Satapathy A; Kumar KN; Horton J; Estivariz CF; Anand A; Sutter R
MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(33):859-63. PubMed ID: 27559683
[TBL] [Abstract][Full Text] [Related]
3. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
Immunization Systems Management Group of the Global Polio Eradication Initiative
MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
[TBL] [Abstract][Full Text] [Related]
4. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
[TBL] [Abstract][Full Text] [Related]
5. Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016.
Shirreff G; Wadood MZ; Vaz RG; Sutter RW; Grassly NC
Emerg Infect Dis; 2017 Feb; 23(2):258-263. PubMed ID: 27861118
[TBL] [Abstract][Full Text] [Related]
6. Fractional-dose inactivated poliovirus vaccination campaign, Telangana state, India, June 2016.
Wkly Epidemiol Rec; 2016 Aug; 91(34):397-403. PubMed ID: 27576292
[No Abstract] [Full Text] [Related]
7. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Oberste MS; Sutter RW; Zaidi AKM
Vaccine; 2017 May; 35(24):3209-3214. PubMed ID: 28479178
[TBL] [Abstract][Full Text] [Related]
8. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
Gamage D; Ginige S; Palihawadana P
WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.
Anand A; Molodecky NA; Pallansch MA; Sutter RW
Vaccine; 2017 May; 35(22):2993-2998. PubMed ID: 28434691
[TBL] [Abstract][Full Text] [Related]
10. Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 - Syria, 2017-2018.
Mbaeyi C; Wadood ZM; Moran T; ; Ather F; Stehling-Ariza T; Nikulin J; Al Safadi M; Iber J; Zomahoun L; Abourshaid N; Pang H; Collins N; Asghar H; Butt OUI; Burns CC; Ehrhardt D; Sharaf M
MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(24):690-694. PubMed ID: 29927908
[TBL] [Abstract][Full Text] [Related]
11. Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
Blake IM; Pons-Salort M; Molodecky NA; Diop OM; Chenoweth P; Bandyopadhyay AS; Zaffran M; Sutter RW; Grassly NC
N Engl J Med; 2018 Aug; 379(9):834-845. PubMed ID: 30157398
[TBL] [Abstract][Full Text] [Related]
12. Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016.
Etsano A; Damisa E; Shuaib F; Nganda GW; Enemaku O; Usman S; Adeniji A; Jorba J; Iber J; Ohuabunwo C; Nnadi C; Wiesen E
MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):770-3. PubMed ID: 27490081
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.
Snider CJ; Zaman K; Estivariz CF; Yunus M; Weldon WC; Wannemuehler KA; Oberste MS; Pallansch MA; Wassilak SG; Bari TIA; Anand A
Lancet; 2019 Jun; 393(10191):2624-2634. PubMed ID: 31104832
[TBL] [Abstract][Full Text] [Related]
14. An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan.
Bullo UF; Mehraj J; Raza SM; Rasool S; Ansari NN; Shaikh AA; Phul ZA; Memon SA; Baloch RI; Baloch ZA; Chandio SA
BMC Public Health; 2021 Jan; 21(1):44. PubMed ID: 33407294
[TBL] [Abstract][Full Text] [Related]
15. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.
Zhao D; Ma R; Zhou T; Yang F; Wu J; Sun H; Liu F; Lu L; Li X; Zuo S; Yao W; Yin J
MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1357-1361. PubMed ID: 29240729
[TBL] [Abstract][Full Text] [Related]
16. Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.
Yaari R; Kaliner E; Grotto I; Katriel G; Moran-Gilad J; Sofer D; Mendelson E; Miller E; Huppert A; ; Anis E; Kopel E; Manor Y; Mor O; Shulman L; Singer R; Weil M
BMC Med; 2016 Jun; 14(1):95. PubMed ID: 27334457
[TBL] [Abstract][Full Text] [Related]
17. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
18. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba.
Resik S; Tejeda A; Mach O; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter R
Vaccine; 2015 Jan; 33(2):307-13. PubMed ID: 25448109
[TBL] [Abstract][Full Text] [Related]
19. Introduction to inactivated polio vaccine and switch from trivalent to bivalent oral poliovirus vaccine worldwide, 2013-2016.
Wkly Epidemiol Rec; 2015 Jul; 90(27):337-43. PubMed ID: 26151981
[No Abstract] [Full Text] [Related]
20. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
